Evidence map›Paper›PMID 35130995›Full record

ArticleEpidemiology and infection2022

Yibin Yang, Xia Zhu, Haixin Zhang, Yuhua Chen, Yongtao Liu, Yi Song, Xiaohui Ai

Abstract read
In one paragraph

Article in Epidemiology and infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Virulence and resistance adaptation of Streptococcus agalactiae Ib/ST261 infecting bullfrogs in Hainan, China between 2019 and 2023.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  3. Article
  4. Article
  5. Toxins · 2025
    Article
  6. Identification and characterization ofMicrobiology spectrum · 2025
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yibin YangYangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan430223, China.ORCID 0000-0002-2605-4627
Xia ZhuYangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan430223, China.
Haixin ZhangJiangxi Fisheries Research Institute, Nanchang, China.
Yuhua ChenDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan430227, China.
Yongtao LiuYangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan430223, China.
Yi SongThe Key Laboratory for Quality and Safety Control of Aquatic Products, Ministry of Agriculture, Beijing100037, China.
Xiaohui AiYangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Wuhan430223, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bullfrog is one of the most important economic aquatic animals in China that is widely cultured in southern China and is a key breed recommended as an industry of poverty alleviation in China. During recent years, a fatal bacterial disease has often been found in cultured bullfrogs. The clinical manifestations of the diseased bullfrogs were severe intestinal inflammation and an anal prolapse. A bacterial pathogen was isolated from the diseased bullfrog intestines. The bacterium was identified as Vibrio cholerae using morphological, biochemical and 16S rRNA phylogenetic analysis. In this study, V. cholerae was isolated and identified in diseased bullfrogs for the first time, providing a basis for the diagnosis and control of the disease. Therefore, attention should be paid to the modes of transmission of V. cholerae from bullfrog and formulate reasonable safety measures.

Indexed as

AquacultureCholeraVibrio choleraeAnimalsAnti-Bacterial AgentsFood MicrobiologyMicrobial Sensitivity TestsRana catesbeianaAnti-Bacterial AgentsBullfrogfatal threatfood safetyroute of transmissionVibrio cholerae

Identifiers

PMID35130995
PMCPMC8888276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.